HUMAN MIXTARD 50 40IU (Insulin Isophane (50%) + Human insulin (50%))

Human Mixtard 50 Injection 40IU/ml is formulated as a blend of two different types of insulin, specifically designed as an intermediate-acting and a short-acting insulin. This medication is primarily utilized for managing diabetes mellitus in both type 1 and type 2 patients, aiding in the regulation of blood glucose levels in individuals, including children and adults. By helping to control blood sugar levels, this injection plays a significant role in the overall treatment of diabetes. It is typically prescribed as part of a broader diabetes management plan that includes other medications, a balanced diet, regular physical activity, and weight management as directed by a healthcare provider. Patients are instructed on the proper subcutaneous injection techniques by their healthcare professionals. It is essential to consume a carbohydrate-rich meal within half an hour following the injection to optimize effectiveness. Patients should continue this treatment only under medical advice, and it is critical to regularly monitor blood glucose levels and document the findings to share with a healthcare provider to ensure the correct dosing is maintained. A major concern associated with this medication is the risk of hypoglycemia, or low blood sugar, which can be mitigated by adhering to prescribed dosages and maintaining regular meal intake. Other potential side effects may include local reactions at the injection site and possible weight gain, among others. It is crucial to avoid using this insulin when blood sugar levels are already low and to inform the healthcare provider about any pre-existing kidney, liver, or heart conditions before starting the therapy. Pregnant or nursing women should also seek professional guidance regarding dosage modifications.